To confirm whether the production of anti-gp210 and/or anti-sp100 antibodies is dependent on AMA-production or not, the sensitivities of anti-gp210 and anti-sp100 in AMA-positive PBC patients in the selected articles were also pooled for comparison (Supplementary 2: Table 2). This evidence concerns the gene SP100 and primary biliary cholangitis.